Kurzübersicht für Early B-Cell Factor 1 (EBF1) (N-Term) Peptid (ABIN976093)
Target
EBF1
(Early B-Cell Factor 1 (EBF1))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
Protein Region
N-Term
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-EBF1 antibody (Catalog #: ARP39578_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
EBF1
Reaktivität: Human, Maus
Wirt: Synthetic
BP, BI
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
EBF1
(Early B-Cell Factor 1 (EBF1))
Hintergrund
TBX22 belongs to the COE family. It contains 1 IPT/TIG domain. TBX22 is a transcriptional activator which recognizes variations of the palindromic sequence 5'-ATTCCCNNGGGAATT-3'.
Alias Symbols: EBF, COE1, OLF1, O/E-1
Protein Interaction Partner: CREBBP,EBF1,PAX5,ZNF423,ZNF521,CREBBP,EBF1,ZNF423